MMB-CHMICA
(Redirected from AMB-CHMICA)
 | |
| Clinical data | |
|---|---|
| Other names | AMB-CHMICA |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H30N2O3 |
| Molar mass | 370.493 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MMB-CHMICA (AMB-CHMICA) is a designer drug and synthetic cannabinoid.[1][2][3] In 2018, it was the sixth-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Administration.[4]
References
[edit]- ^ Göl E, Çok I (January 2019). "New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey". Forensic Science International. 294: 113–123. doi:10.1016/j.forsciint.2018.11.003. PMID 30502695. S2CID 56176934.
- ^ Mardal M, Dalsgaard PW, Qi B, Mollerup CB, Annaert P, Linnet K (April 2018). "Metabolism of the synthetic cannabinoids AMB-CHMICA and 5C-AKB48 in pooled human hepatocytes and rat hepatocytes analyzed by UHPLC-(IMS)-HR-MSE". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1083: 189–197. doi:10.1016/j.jchromb.2018.03.016. PMID 29549742.
- ^ Wagmann L, Stiller RG, Fischmann S, Westphal F, Meyer MR (October 2022). "Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases". Archives of Toxicology. 96 (10): 2755–2766. doi:10.1007/s00204-022-03332-z. PMC 9352624. PMID 35788413. S2CID 250281976.
- ^ "Emerging Threat Report: Annual 2018" (PDF). Special Testing and Research Laboratory, Drug Enforcement Administration.